检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李婷[1,2] 张颖[3] 李凤飞[3] 朱红红[3] 周佩华[3] 孙进[3] 卢春峰[3] 苏晓飞[3] 马建华[1,3]
机构地区:[1]南京医科大学,江苏南京210029 [2]南京卫生学校,江苏联合职业技术学院南京卫生分院护理系,江苏南京210038 [3]南京医科大学附属南京医院(南京市第一医院)内分泌科,江苏南京210012
出 处:《东南大学学报(医学版)》2017年第3期323-327,共5页Journal of Southeast University(Medical Science Edition)
基 金:中国博士后基金资助项目(2015M581829);江苏省科技厅科学基金资助项目(BL2014010);南京市卫生局项目(YKK11110)
摘 要:目的:比较精蛋白锌重组赖脯胰岛素混和注射液50R(优泌乐50)和门冬胰岛素30注射液(诺和锐30)对2型糖尿病(T2DM)患者血糖波动的影响。方法:入组T2DM患者持续皮下输注胰岛素强化,血糖达标2 d后行优泌乐50或诺和锐30每日3次治疗,血糖再次达标后进入4 d交叉研究,全程96 h动态血糖监测(CGM)覆盖。结果:优泌乐50和诺和锐30对患者24 h平均血糖、平均血糖波动幅度(MAGE)、高血糖(>10.0 mmol·L^(-1))和低血糖(<3.9 mmol·L^(-1))曲线下面积(AUC)等差异均无统计学意义;但相同剂量的优泌乐50较诺和锐30能更好地改善男性患者的MAGE[(4.52±2.50)vs(5.53±1.90)mmol·L^(-1),P<0.05];两组患者均无低血糖事件发生。结论:中、低预混胰岛素类似物对T2DM患者总人群血糖波动的影响相似,但中预混胰岛素能更好地控制男性T2DM患者血糖波动。Objective: To compare the effect of mixed protamine zinc recombinant human insulin lispro injection 50R(Humalog Mix 50) with that of insulin aspart 30 injection(Novo Mix 30)on glycemic variations in patients with type 2 diabetes mellitus(T2DM).Methods: The recruited patients were treated with continuous subcutaneous insulin infusion for achieving euglycemic control.The patients were then treated with Humalog Mix 50 or Novo Mix 30 thrice-daily for another 2 days followed by 4-day cross-over treatment.Continuous glucose monitoring(CGM) was performed in all the subjects for at least 96 hours during the cross-over study period.The 24 hour mean glucose(24 hr MG), the mean amplitude of glycemic excursions(MAGE) and the incremental area under curve(AUC) of glucose concentrations above 10 mmol·L-1 or less than 3.9 mmol·L-1 were analyzed.Results: There were no significant differences in the 24 hr MG, the MAGE and the incremental AUC〉10.0 mmol·L-1 or &lt;3.9 mmol·L-1 between the groups.However, the MAGE was significantly improved in male patients with T2DM treated with Humalog Mix 50 compared with those treated with Novo Mix 30.Conclusion: T2DM patients treated with middle or low premixed insulin analogue have similar improvement of glycemic variations.Moreover, male patients treated with middle premixed insulin analogue get better improvement in glycemic variations compared with those treated with low premixed insulin analogue therapy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.149.235.7